2025-11-13T13:30:22-06:00 2024-12-31 410746749 CLIFTONLARSONALLEN LLP 2001 16TH STREET SUITE 1700 DENVER CO 80202 990 2024-01-01 841122993 THE COLORADO PREVENTION CENTER COLO 3038909900 2115 N SCRANTON STREET 2040 AURORA CO 80045 DAVID KOENIG VP OF FINANCE 3038909900 2025-11-12 1 1 REBECCA DETTMANN CPA P01408585 3037795710 2025-11-12 2024 2025-03-06 01:10:19Z CPC CLINICAL RESEARCH & MARC P BONACA MD MPH 2115 N SCRANTON STREET 2040 AURORA CO 80045 39256394 0 X CPCCLINICALRESEARCH.ORG X 1989 CO IMPROVING HEALTH THROUGH INNOVATIVE SCIENCE AND COMMUNITY ENGAGEMENT. 15 14 127 16 0 0 1110859 1128069 22216429 37396168 478829 685391 24451 13996 23830568 39223624 5400 0 0 0 8990801 11841296 0 0 15123 14138167 25820728 23134368 37662024 696200 1561600 29694066 38163287 14951930 21439285 14742136 16724002 IMPROVING HEALTH THROUGH INNOVATIVE SCIENCE AND COMMUNITY ENGAGEMENT. 0 0 33511962 0 37384918 CLINICAL RESEARCHTHE PURPOSE OF CPC'S CLINICAL RESEARCH PROGRAM IS TO UNITE ACADEMIC LEADERSHIP WITH OPERATIONAL EXPERTISE TO OPTIMIZE THE QUALITY OF CLINICAL RESEARCH AND IMPROVE HEALTH. CPC IS AFFILIATED WITH THE UNIVERSITY OF COLORADO HEALTH ANSCHUTZ MEDICAL CAMPUS AND DENVER HEALTH & HOSPITAL AUTHORITY AND PROVIDES EXPERTISE IN TRIAL MANAGEMENT AND EDUCATIONAL TRAINING FOR CLINICAL RESEARCH INCLUDING MEDICAL AFFAIRS, BIOSTATISTICAL ANALYSIS, DATA AND PROJECT MANAGEMENT AND REGULATORY AFFAIRS. 1047931 0 11250 CPC COMMUNITY HEALTHTHE PURPOSE OF CPC'S COMMUNITY HEALTH PROGRAM IS TO IMPROVE THE HEALTH OF ALL COLORADANS BY CREATING INNOVATIVE COMMUNITY HEALTH PROGRAMS THAT DELIVER EVIDENCE-BASED INTERVENTIONS. CARDIOVASCULAR DISEASE IS THE LEADING CAUSE OF DEATH IN THE STATE OF COLORADO. DESPITE THE AVAILABILITY OF NATIONAL GUIDELINES, FEW PATIENTS ARE APPROPRIATELY TREATED FOR THE RISK FACTORS SUCH AS HYPERTENSION AND DIABETES THAT LEAD TO THIS EPIDEMIC. 34559893 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 97 0 1 127 1 0 0 0 0 0 0 0 0 0 0 0 0 X 15 14 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 0 0 0 X DAVID KOENIG 3038609900 2115 SCRANTON ST SUITE 2040 AURORA CO 80045 X MARC P BONACA MD MPH EXECUTIVE DIRECTOR 50.00 X X 328537 0 47134 MARC R BRADAC CPC MT PUBLIC DIRECTOR-CHAIRMAN 1.00 X X 0 0 0 CLAY ANSELMO PUBLIC DIRECTOR-ACT TREASURER 1.00 X X 0 0 0 ROBERT HUNTER SECRETARY (THRU 2/24) 1.00 X X 0 0 0 LARRY ALLEN MD PERMANENT DIRECTOR 1.00 X 0 0 0 CATHY BRADLEY MD PERMANENT DIRECTOR 1.00 X 0 0 0 VINEET CHOPRA MD MSC PERMANENT DIRECTOR 1.00 X 0 0 0 DONALD ELLIMAN JR PERMANENT DIRECTOR 1.00 X 0 0 0 TOM FLAIG MD PERMANENT DIRECTOR 1.00 X 0 0 0 APRIL GILES PUBLIC DIRECTOR 1.00 X 0 0 0 KIMBERLY NECKERS PUBLIC DIRECTOR 1.00 X 0 0 0 ROBERT PRICE PUBLIC DIRECTOR 1.00 X 0 0 0 JOHN SAMPSON MD PHD MBA PERMANENT DIRECTOR 1.00 X 0 0 0 CHARLES SCOGGIN MD PUBLIC DIRECTOR 1.00 X 0 0 0 LAURA L SIMON MD PUBLIC DIRECTOR 1.00 X 0 0 0 KELSEY WASYLENKY ESQ PUBLIC DIRECTOR 1.00 X 0 0 0 JOHN REILLY JR MD PERM. DIRECTOR (THRU 6/24) 1.00 X 0 0 0 DAVID KOENIG VP, FINANCE 40.00 X 224350 0 46506 DAVID POTICHA GENERAL COUNSEL 40.00 X 233612 0 19713 JUDITH HSIA CHIEF MEDICAL OFFICER 50.00 X 231313 0 23760 JORDAN GORJIYAN - DIRECTOR OF IS, BIOSTATISTICS AND DATA MGMT 40.00 X 200383 0 18892 CONNIE HESS CLINICIAN-SCIENTIST 40.00 X 187971 0 29576 VICTORIA ANDERSON DIRECTOR OF OPERATIONS 40.00 X 186006 0 14246 1592172 0 199827 7 0 1 1 ALBERT EINSTEIN CNPJ 60765823/0001-30 AV SAO PAULO BR 05652-000 CLINICAL TRIAL MANAGEMENT SERVICES 4173131 GEORGE CLINICAL PTY LTD LEVEL 5 1 KING STREET NEWTON SOUTH WALES AS CLINICAL TRIAL MANAGEMENT SERVICES 2598663 ALMAC CLINICAL SERVICES PO BOX 411295 BOSTON MA 02241 CLINICAL TRIAL SERVICES 1413653 UNIVERSITY OF COLORADO 13120 E 19TH AVENUE AURORA CO 80045 FACILITY SERVICES 1297095 HUMA THERAPEUTICS LTD 13TH FLOOR MILLBANK TOWER LONDON UK SW 1P 4QP CLINICAL TRIAL STATISTICAL ANALYSIS AND 1051068 26 979800 148269 1128069 CLINICAL RESEARCH 541700 37379658 37379658 CONTRACT REVENUE 541700 16510 16510 37396168 640232 640232 77929 32770 45159 45159 45159 MISCELLANEOUS REVENUE 900099 13996 13996 13996 39223624 37396168 0 699387 646527 225402 421125 9304483 8171226 1133257 253079 229181 23898 964257 845194 119063 672950 570676 102274 17450 16002 1448 48519 44494 4025 42946 42946 3189416 2924818 264598 13012 11734 1262 16 78846 71105 7646 95 654708 264808 388425 1475 580738 234889 344540 1309 133554 120442 12951 161 36735 33129 3562 44 17288 11801 5426 61 313378 188546 123761 1071 134652 121432 13058 162 PROJECT EXPENSES 20389503 20389503 BAD DEBT 37744 37744 INTERCOMPANY EXPENSE 31419 31419 DUES AND SUBSCRIPTIONS 26546 23940 2574 32 74274 61571 2006 10697 37662024 34559893 3087008 15123 6036921 938815 881 12173758 234447 194865 4163714 3701485 34740 497374 1779943 2327681 1293179 1260751 1034502 14783979 15853763 2715999 2451416 29694066 38163287 3002871 5000143 8575626 13474182 305820 266172 3067613 2698788 14951930 21439285 X 13646990 15515940 1095146 1208062 14742136 16724002 29694066 38163287 1561600 420266 0 X X 0 1 X 1 0 X UNIVERSITY OF COLORADO DENVER CO RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2919320 84697 301226 3305243 2238176 369258 311886 2919320 1774357 800230 -336411 2238176 1745924 28433 1774357 0.63450 0.36550 0.00000 0 0 1558151 705262 852889 520939 415185 105754 248591 172732 75859 1034502 RIGHT OF USE ASSET 1798582 DUE FROM AN AFFILIATE 652834 2451416 OPERATING LEASE LIABILITY 2698788 2698788 X 39584434 420266 -16510 403756 39180678 42946 42946 39223624 37587659 -31419 -31419 37619078 42946 42946 37662024 PART V, LINE 4: IN 2021, THE BOARD OF DIRECTORS ESTABLISHED THE WILLIAM R. HIATT VASCULAR MEDICINE FELLOWSHIP ENDOWMENT (HIATT FELLOWSHIP ENDOWMENT), THE PURPOSE OF WHICH IS TO PROVIDE A PERMANENT FUNDING MECHANISM TO SUPPORT A VASCULAR MEDICINE FELLOW AT THE UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, WITH CLINICAL TRAINING AND RESEARCH PRODUCTIVITY COMPONENTS. THIS ENDOWMENT FUND IS INTENDED TO INCLUDE BOARD-DESIGNATED CONTRIBUTIONS AS WELL AS DONOR-RESTRICTED CONTRIBUTIONS. THE BOARD OF DIRECTORS ALSO ESTABLISHED THE WILLIAM R. HIATT ENDOWMENT FOR CLINICAL RESEARCH (HIATT CLINICAL RESEARCH ENDOWMENT), THE INTENT AND PURPOSE OF WHICH ARE TO PROVIDE A PERPETUAL GRANT FUNDING MECHANISM TO SUPPORT SCIENTIFIC INITIATIVES AND EDUCATION AT CPC. THIS ENDOWMENT FUND IS INTENDED TO INCLUDE BOARD-DESIGNATED CONTRIBUTIONS AS WELL AS DONOR-RESTRICTED CONTRIBUTIONS. PART X, LINE 2: THE CENTER IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION. INCOME FROM ACTIVITIES NOT DIRECTLY RELATED TO ITS TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. THERE WAS NO UNRELATED TAXABLE INCOME IN 2024 AND 2023. MANAGEMENT IS REQUIRED TO EVALUATE TAX POSITIONS TAKEN BY THE CENTER AND TO RECOGNIZE A TAX LIABILITY IF THE CENTER HAVE TAKEN AN UNCERTAIN POSITION THAT MORE-LIKELY-THAN-NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. THE CENTER BELIEVES IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND THAT NONE WOULD REQUIRE RECOGNITION OF A LIABILITY OR DISCLOSURE IN THE FINANCIAL STATEMENTS. THE CENTER IS SUBJECT TO ROUTINE AUDITS BY TAX JURISDICTIONS; HOWEVER, THERE ARE CURRENTLY NO AUDITS FOR ANY TAX PERIODS IN PROGRESS. THE THREE PERVIOUS TAX YEARS REMAIN SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE. PART XI, LINE 2D - OTHER ADJUSTMENTS: CONSOLIDATED AFS - REVENUE FROM SEPARATE FILING ENTITY 31,419. CONSOLIDATED AFS - ELIMINATIONS TO CONSOLIDATE AFS -47,929. PART XII, LINE 2D - OTHER ADJUSTMENTS: CONSOLIDATED AFS - EXPENSES FROM SEPARATE FILING ENTITY 16,510. CONSOLIDATED AFS - ELIMINATIONS TO CONSOLIDATE AFS -47,929. EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES CLINICAL TRIAL MANAGEMENT SERVICES 2598663 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES CLINICAL TRIAL STATISTICAL ANALYSIS 1051068 SOUTH AMERICA 0 0 PROGRAM SERVICES CLINICAL TRIAL MANAGEMENT SERVICES 4173131 0 0 0 0 0 0 7822862 0 7822862 0 0 0 0 0 0 PART I, LINE 3: THE ORGANIZATION USED THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR EXPENDITURES IN PART I COLUMN (F). 0 0 0 1 0 0 0 0 0 MARC P BONACA MD MPH EXECUTIVE DIRECTOR 328537 0 0 0 0 0 26575 0 20559 0 375671 0 0 0 DAVID KOENIG VP, FINANCE 219350 0 5000 0 0 0 9402 0 37104 0 270856 0 0 0 JUDITH HSIA CHIEF MEDICAL OFFICER 231313 0 0 0 0 0 23131 0 629 0 255073 0 0 0 DAVID POTICHA GENERAL COUNSEL 228612 0 5000 0 0 0 8892 0 10821 0 253325 0 0 0 JORDAN GORJIYAN - DIRECTOR OF IS, BIOSTATISTICS AND DATA MGMT 195383 0 5000 0 0 0 8071 0 10821 0 219275 0 0 0 CONNIE HESS CLINICIAN-SCIENTIST 187971 0 0 0 0 0 14412 0 15164 0 217547 0 0 0 VICTORIA ANDERSON DIRECTOR OF OPERATIONS 181006 0 5000 0 0 0 1425 0 12821 0 200252 0 0 0 PART I, LINE 5 EXECUTIVE DIRECTOR AND HIGHEST COMPENSATED EMPLOYEES RECEIVE BONUSES BASED ON 1. REVENUE LEVEL ACHIEVED DURING THE FISCAL YEAR AND 2. OPERATING MARGIN ACHIEVED DURING THE FISCAL YEAR. FORM 990, PART VII, SECTION A, LINE 5 THE COLORADO PREVENTION CENTER (THE CENTER) REIMBURSES THE UNIVERSITY OF COLORADO DENVER AND DENVER HEALTH AND HOSPITAL AUTHORITY, AN UNRELATED ORGANIZATION, FOR THE TIME OF CERTAIN EMPLOYEES OF THOSE ORGANIZATIONS SPENT WORKING FOR THE CENTER. THESE AMOUNTS HAVE BEEN INCLUDED AS WAGES PAID BY THE CENTER ON PART VII , PART IX AND ON SCHEDULE J. THIS INCLUDES THE SALARY OF INDIVIDUALS LISTED IN PART VII, AS WELL AS OTHER PHYSICIANS NOT LISTED ON PART VII OR SCHEDULE J. FORM 990, PART I, ITEM C DBA: CPC COMMUNITY HEALTH FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE CHAIRMAN OF THE BOARD, THE VICE CHAIRMAN OF THE BOARD, THE PRESIDENT, THE VICE-PRESIDENT(S), THE SECRETARY AND THE TREASURER. THE EXECUTIVE COMMITTEE SHALL HAVE SUCH POWER AS IS DELEGATED TO IT BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 2 LAURA SIMON AND DONALD ELLIMAN, JR. HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B CPC'S 990 IS REVIEWED BY OUR VP OF FINANCE AND CONTROLLER AND THEN REVIEWED BY THE FINANCE COMMITTEE. FORM 990, PART VI, SECTION B, LINE 12C ANNUAL CONFLICT OF INTEREST DISCLOSURES ARE SIGNED BY ALL MEMBERS OF THE BOARD OF DIRECTORS AND THE COMPLETION OF SUCH IS MONITORED BY THE DIRECTOR OF HR. ANY CONFLICTS ARE MADE KNOWN TO THE FULL BOARD OF DIRECTORS THROUGH A WRITTEN PROCEDURE AT ANY TIME WHEN SUCH INTEREST SHALL BECOME A MATTER INVOLVING BOARD ACTION. IF A CONFLICT OF INTEREST OCCURS, THE DIRECTOR SHALL NOT VOTE ON ANY PERTINENT MATTER. FORM 990, PART VI, SECTION B, LINE 15 AT CPC WE COLLECT MARKET DATA (E.G. COMPENSATION SURVEYS) TO ESTABLISH/UPDATE PAY RANGES FOR ALL POSITIONS INCLUDING KEY ROLES AND HAVE A PROCESS IN PLACE WHEN DETERMINING COMPENSATION TO ENSURE PAY EQUITY. THE PAY RANGES ARE UPDATED AT MINIMUM EVERY OTHER YEAR. LAST TIME THIS OCCURRED WAS IN 2024. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART VII - ADDITIONAL INFORMATION THE COLORADO PREVENTION CENTER (THE CENTER) REIMBURSES THE UNIVERSITY OF COLORADO DENVER AND DENVER HEALTH AND HOSPITAL AUTHORITY, AN UNRELATED ORGANIZATION, FOR THE TIME OF CERTAIN EMPLOYEES OF THOSE ORGANIZATIONS SPENT WORKING FOR THE CENTER. THESE AMOUNTS HAVE BEEN INCLUDED AS WAGES PAID BY THE CENTER ON PART VII , PART IX AND ON SCHEDULE J. THIS INCLUDES THE SALARY OF INDIVIDUALS LISTED IN PART VII, AS WELL AS OTHER PHYSICIANS NOT LISTED ON PART VII OR SCHEDULE J. FORM 990, PART XII, LINE 2C: THE PROCESS FOR OVERSIGHT AND SELECTION OF AN INDEPENDENT ACCOUNTANT HAS NOT CHANGED FROM THE PRIOR YEAR. COLORADO CLINICAL RESEARCH 2115 N SCRANTON STREET AURORA CO 80045 205990402 RESEARCH CO THE COLORADO PREVENTION CENTER C 31419 1.00000 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 COLORADO CLINICAL RESEARCH D 652834 BOOK VALUE